ICON plc
As a Risk-Based Study Management Lead at ICON, you will provide end-to-end risk oversight for assigned clinical studies, ensuring risks to patient safety, data quality, and trial integrity are proactively managed. You will partner with Clinical Research Managers to facilitate risk-focused discussions, drive mitigation strategies, and ensure alignment with regulatory standards like ICH-GCP. This role requires an analytical mindset to interpret data trends and contribute to inspection readiness through clear documentation.
ICON plc is a global clinical research organisation (CRO) that provides outsourced clinical development and commercialisation services to pharmaceutical, biotechnology and medical device companies. It offers end-to-end drug and device development support — including clinical trial management across phases, data management and biostatistics, regulatory and safety/pharmacovigilance, and commercialisation and market-access services. ICON combines scientific and therapeutic expertise with technology and a scalable global operations network to accelerate development and bring therapies to patients. Clients engage ICON for integrated, experienced CRO support across the full product lifecycle.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ICON plc.
ICON plc didn’t post a salary, so this is our estimate from similar listings.
29% below the average for this role